がん治療、光免疫療法で研究所　開発者の小林所長会見―関西医大

　関西医科大（大阪府枚方市）は２０日までに、「第５のがん治療」として期待される光免疫療法の「光免疫医学研究所」を開設した。治療法の開発者で、所長に就いた小林久隆特別教授は同日の記者会見で、「１０年後をめどに８割のがんを治療できるようにしたい。たくさんの患者に喜んでもらえるゴールに向かって研究を進めたい」と抱負を語った。
　研究所には治療機器の開発、免疫研究、患者の検体を調べる病理学などの部門を設けた。約３０人体制で、基礎研究から臨床支援までカバーする。（2022/04/20-21:13）

Kansai Medical University has established a new center for research on photoimmunotherapy, which is called "the fifth treatment for cancer."
   The research center in the western Japan city of Hirakata, Osaka Prefecture, is headed by Prof. Hisataka Kobayashi, who developed the treatment method.
   "We aim to be able to treat 80 pct of cancer cases with the method in 10 years," Kobayashi told a press conference Wednesday. "We will advance our research towards the goal of making many patients happy."
   The roughly 30-member center, which includes departments on the development of treatment equipment, on immunology research and on pathology, will cover a wide range of activities, from basic research to support for clinical trials.
   In photoimmunotherapy, patients are administered an antibody drug that binds with cancer cells. Laser beams are applied to patients the following day, destroying only the cells.